≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Other blood glucose lowering drugs, excl. Insulins

PheWeb

GLUCLOW_OTH

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC A10BX

8290

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

4732

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

4732

diagram downward connector

Include endpoints None

4732

diagram downward connector
GLUCLOW_OTH

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 4732 2389 2343
Unadjusted prevalence (%) 1.33 1.20 1.49
Mean age at first event (years) 57.73 56.72 58.76

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.73 [1.35, 2.20] 1.1e-5 766
15 years 0.01 1.23 [1.00, 1.52] 4.5e-2 367
5 years 0.00 1.82 [1.48, 2.25] 2.2e-8 157
1 year 0.00 1.29 [0.81, 2.04] 2.8e-1 20

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: GLUCLOW_OTH – Other blood glucose lowering drugs, excl. Insulins
GWS hits:

Survival analyses between endpoints

↥

Plot

before Other blood glucose lowering drugs, excl. Insulins
after Other blood glucose lowering drugs, excl. Insulins

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other blood glucose lowering drugs, excl. Insulins

↥